- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Tyrosinemia Type 2
Total 57430 results
-
Lawson Health Research InstituteJanssen Inc.CompletedType 2 Diabetes MellitusCanada
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Maastricht University Medical CenterNovo Nordisk A/SCompletedType 2 DiabetesNetherlands
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
CymaBay Therapeutics, Inc.TerminatedType 2 Diabetes MellitusUnited States, India
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Tel Aviv UniversityCompletedType 2 Diabetes MellitusIsrael
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Nagaoka Red Cross HospitalKurume UniversityUnknownType 2 Diabetes MellitusJapan
-
Tirang R. NeyestaniTehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Cytos Biotechnology AGCompletedType 2 Diabetes MellitusGermany, Switzerland
-
TakedaCompleted
-
TakedaCompletedType 2 Diabetes Mellitus
-
National Taiwan University HospitalNational Science Council, TaiwanCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
GlaxoSmithKlineCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
-
Landsteiner InstitutMedical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaboratorsCompletedType 2 Diabetes MellitusAustria
-
University of Campania "Luigi Vanvitelli"CompletedType 2 Diabetes MellitusItaly
-
National Institute of Nursing Research (NINR)CompletedType 2 Diabetes MellitusUnited States
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
Universidad de Los LagosUniversidad de La FronteraCompletedHyperglycemia | Exercise Training | Type2 Diabetes Mellitus | Heart RateChile
-
University of MinnesotaActive, not recruitingHypoglycemia | Type 2 Diabetes MellitusUnited States
-
University of Campania "Luigi Vanvitelli"CompletedType 2 Diabetes MellitusItaly
-
Population Health Research InstituteNovo Nordisk A/SCompletedType 2 Diabetes MellitusCanada
-
Northwell HealthPatient-Centered Outcomes Research InstituteCompletedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
University of MinnesotaUniversity of Southern California; Wake Forest UniversityCompleted
-
Joslin Diabetes CenterDHR Health Institute for Research and Development; Verizon FoundationCompletedType 2 Diabetes MellitusUnited States
-
Pendulum TherapeuticsTerminatedType 2 Diabetes MellitusIreland
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
-
Marja-Riitta TaskinenGöteborg UniversityCompletedType 2 Diabetes MellitusFinland
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)CompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusGermany
-
Massachusetts General HospitalCompletedType 2 Diabetes MellitusUnited States
-
Ankara Yildirim Beyazıt UniversityCompletedType 2 Diabetes Mellitus | BalanceTurkey
-
Karolinska InstitutetCompletedType 2 Diabetes MellitusSweden
-
PegBio Co., Ltd.CovanceCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Evidation HealthOne DropCompletedType 2 Diabetes MellitusUnited States
-
Massachusetts General HospitalCompletedType 2 Diabetes MellitusUnited States